Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

QIAGEN Revenue 2006-2018 | QGEN

QIAGEN annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • QIAGEN revenue for the quarter ending September 30, 2018 was $0.378B, a 3.83% increase year-over-year.
  • QIAGEN revenue for the twelve months ending September 30, 2018 was $1.496B, a 7.81% increase year-over-year.
  • QIAGEN annual revenue for 2018 was $1.502B, a 5.95% increase from 2017.
  • QIAGEN annual revenue for 2017 was $1.418B, a 5.95% increase from 2016.
  • QIAGEN annual revenue for 2016 was $1.338B, a 4.45% increase from 2015.
QIAGEN Annual Revenue
(Millions of US $)
2018 $1,502
2017 $1,418
2016 $1,338
2015 $1,281
2014 $1,345
2013 $1,302
2012 $1,254
2011 $1,170
2010 $1,087
2009 $1,010
2008 $893
2007 $650
2006 $466
2005 $398
QIAGEN Quarterly Revenue
(Millions of US $)
Q3 2018 $378
Q2 2018 $377
Q1 2018 $344
Q4 2017 $397
Q3 2017 $364
Q2 2017 $349
Q1 2017 $308
Q4 2016 $367
Q3 2016 $339
Q2 2016 $334
Q1 2016 $298
Q4 2015 $349
Q3 2015 $315
Q2 2015 $319
Q1 2015 $298
Q4 2014 $360
Q3 2014 $336
Q2 2014 $331
Q1 2014 $317
Q4 2013 $361
Q3 2013 $322
Q2 2013 $315
Q1 2013 $304
Q4 2012 $347
Q3 2012 $304
Q2 2012 $307
Q1 2012 $296
Q4 2011 $334
Q3 2011 $289
Q2 2011 $282
Q1 2011 $264
Q4 2010 $286
Q3 2010 $274
Q2 2010 $263
Q1 2010 $264
Q4 2009 $289
Q3 2009 $260
Q2 2009 $240
Q1 2009 $221
Q4 2008 $237
Q3 2008 $231
Q2 2008 $218
Q1 2008 $207
Q4 2007 $210
Q3 2007 $177
Q2 2007 $135
Q1 2007 $128
Q4 2006 $126
Q3 2006 $118
Q2 2006 $113
Q1 2006 $109
Q4 2005 $104
Q3 2005 $99
Q2 2005 $100
Q1 2005 $95
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.716B $1.502B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.167B 12.95
Gilead Sciences (GILD) United States $85.858B 10.77
Biogen (BIIB) United States $63.873B 12.38
Celgene (CELG) United States $63.569B 11.78
Vertex Pharmaceuticals (VRTX) United States $47.481B 63.60
Regeneron Pharmaceuticals (REGN) United States $45.346B 21.06
Illumina (ILMN) United States $42.993B 51.13
Alexion Pharmaceuticals (ALXN) United States $28.142B 17.44
Incyte (INCY) United States $17.752B 166.84
BioMarin Pharmaceutical (BMRN) United States $16.643B 0.00
Seattle Genetics (SGEN) United States $11.010B 0.00
Exact Sciences (EXAS) United States $10.830B 0.00
Sarepta Therapeutics (SRPT) United States $9.013B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.401B 0.00
BeiGene (BGNE) Cayman Islands $8.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.345B 0.00
Bio-Techne Corp (TECH) United States $7.121B 47.98
Exelixis (EXEL) United States $6.667B 15.59
Moderna (MRNA) United States $6.467B 0.00
Amarin (AMRN) Ireland $5.603B 0.00
Galapagos (GLPG) Belgium $5.280B 0.00
Alkermes (ALKS) Ireland $5.050B 0.00
Array BioPharma (ARRY) United States $4.809B 0.00
Guardant Health (GH) United States $4.191B 0.00
Horizon Pharma Public (HZNP) Ireland $3.844B 15.81
Allogene Therapeutics (ALLO) United States $3.783B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.759B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.424B 0.00
Emergent Biosolutions (EBS) United States $3.312B 27.90
Intercept Pharmaceuticals (ICPT) United States $3.298B 0.00
Blueprint Medicines (BPMC) United States $3.276B 0.00
Ascendis Pharma (ASND) Denmark $2.965B 0.00
Genomic Health (GHDX) United States $2.945B 99.42
Ultragenyx Pharmaceutical (RARE) United States $2.805B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.743B 0.00
China Biologic Products (CBPO) China $2.688B 19.13
Immunomedics (IMMU) United States $2.668B 0.00
Global Blood Therapeutics (GBT) United States $2.640B 0.00
Repligen (RGEN) United States $2.580B 80.57
Ligand Pharmaceuticals (LGND) United States $2.569B 18.45
Reata Pharmaceuticals (RETA) United States $2.559B 0.00
Mirati Therapeutics (MRTX) United States $2.504B 0.00
Akcea Therapeutics (AKCA) United States $2.399B 0.00
Halozyme Therapeutics (HALO) United States $2.391B 53.35
Arena Pharmaceuticals (ARNA) United States $2.379B 0.00
Myriad Genetics (MYGN) United States $2.265B 23.07
Amicus Therapeutics (FOLD) United States $2.122B 0.00
Insmed (INSM) United States $2.012B 0.00
Acceleron Pharma (XLRN) United States $1.929B 0.00
Denali Therapeutics (DNLI) United States $1.924B 0.00
Spark Therapeutics (ONCE) United States $1.910B 0.00
AnaptysBio (ANAB) United States $1.851B 0.00
Atara Biotherapeutics (ATRA) United States $1.800B 0.00
Medicines (MDCO) United States $1.773B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.770B 0.00
MyoKardia (MYOK) United States $1.691B 0.00
REGENXBIO (RGNX) United States $1.666B 22.34
NeoGenomics (NEO) United States $1.629B 134.08
CRISPR Therapeutics AG (CRSP) Switzerland $1.605B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.600B 0.00
Myovant Sciences (MYOV) United Kingdom $1.522B 0.00
Innoviva (INVA) United States $1.488B 4.10
Allakos (ALLK) United States $1.485B 0.00
Aimmune Therapeutics (AIMT) United States $1.385B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.360B 0.00
Clovis Oncology (CLVS) United States $1.343B 0.00
UniQure (QURE) Netherlands $1.341B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.237B 0.00
Lion Biotechnologies (IOVA) United States $1.217B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.210B 0.00
Cambrex (CBM) United States $1.201B 12.97
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.182B 0.00
Codexis (CDXS) United States $1.177B 0.00
Rubius Therapeutics (RUBY) United States $1.083B 0.00
WAVE Life Sciences (WVE) Singapore $1.076B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.055B 42.81
Deciphera Pharmaceuticals (DCPH) United States $1.053B 0.00
Puma Biotechnology (PBYI) United States $1.035B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.022B 0.00
Audentes Therapeutics (BOLD) United States $1.021B 0.00
Epizyme (EPZM) United States $0.987B 0.00
Coherus BioSciences (CHRS) United States $0.965B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.964B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.955B 0.00
Editas Medicine (EDIT) United States $0.950B 0.00
Fate Therapeutics (FATE) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.919B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Novavax (NVAX) United States $0.842B 0.00
Athenex (ATNX) United States $0.836B 0.00
Vericel (VCEL) United States $0.833B 0.00
CytomX Therapeutics (CTMX) United States $0.832B 0.00
Apellis Pharmaceuticals (APLS) United States $0.799B 0.00
G1 THERAPEUTICS (GTHX) United States $0.779B 0.00
Intra-Cellular Therapies (ITCI) United States $0.745B 0.00
Heska (HSKA) United States $0.741B 60.67
Acorda Therapeutics (ACOR) United States $0.740B 9.60
Y-mAbs Therapeutics (YMAB) United States $0.732B 0.00
InflaRx (IFRX) Germany $0.729B 0.00
Arvinas (ARVN) United States $0.727B 0.00
Cellectis (CLLS) France $0.711B 0.00
Principia Biopharma (PRNB) United States $0.698B 0.00
ANI Pharmaceuticals (ANIP) United States $0.698B 13.34
Dicerna Pharmaceuticals (DRNA) United States $0.672B 0.00
Dynavax Technologies (DVAX) United States $0.661B 0.00
Revance Therapeutics (RVNC) United States $0.659B 0.00
RA PHARMCTL INC (RARX) United States $0.659B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.655B 0.00
Cara Therapeutics (CARA) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.647B 0.00
Twist Bioscience (TWST) United States $0.628B 0.00
Intellia Therapeutics (NTLA) United States $0.603B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.564B 0.00
UROGEN PHARMA (URGN) Israel $0.557B 0.00
Anika Therapeutics (ANIK) United States $0.555B 22.98
Kura Oncology (KURA) United States $0.551B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.550B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.542B 0.00
Osiris Therapeutics (OSIR) United States $0.525B 0.00
Eidos Therapeutics (EIDX) United States $0.517B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
Zymeworks (ZYME) Canada $0.496B 0.00
Arcus Biosciences (RCUS) United States $0.478B 0.00
Synthorx (THOR) United States $0.477B 0.00
UNITY Biotechnology (UBX) $0.476B 0.00
PDL BioPharma (PDLI) United States $0.472B 7.69
DBV Technologies (DBVT) France $0.467B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.457B 0.00
Zealand Pharma (ZEAL) Denmark $0.452B 4.98
Clementia Pharmaceuticals (CMTA) Canada $0.444B 0.00
ObsEva SA (OBSV) Switzerland $0.436B 0.00
Agenus (AGEN) United States $0.425B 0.00
Replimune (REPL) United States $0.424B 0.00
Senesco Technologies (ELOX) United States $0.419B 0.00
Cytokineticsorporated (CYTK) United States $0.417B 0.00
Scholar Rock Holding (SRRK) United States $0.416B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.414B 0.00
Five Prime Therapeutics (FPRX) United States $0.408B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
OSMOTICA PHARM (OSMT) United States $0.394B 0.00
Kezar Life Sciences (KZR) United States $0.388B 0.00
Sinovac Biotech (SVA) China $0.379B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.366B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.360B 0.00
Kindred Biosciences (KIN) United States $0.355B 0.00
Stemline Therapeutics (STML) United States $0.353B 0.00
Inovio Pharmaceuticals (INO) United States $0.352B 0.00
AVROBIO (AVRO) United States $0.352B 0.00
Cellular Biomedicine (CBMG) United States $0.350B 0.00
MeiraGTx Holdings (MGTX) United States $0.349B 0.00
Gritstone Oncology (GRTS) United States $0.327B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.326B 0.00
Krystal Biotech (KRYS) United States $0.321B 0.00
Urovant Sciences (UROV) United States $0.318B 0.00
BioDelivery Sciences (BDSI) United States $0.318B 0.00
XBiotech (XBIT) United States $0.315B 0.00
Abeona Therapeutics (ABEO) United States $0.312B 0.00
Albireo Pharma (ALBO) United States $0.309B 0.00
Evelo Biosciences (EVLO) United States $0.305B 0.00
Gamida Cell (GMDA) Israel $0.304B 0.00
Enochian BioSciences (ENOB) United States $0.299B 0.00
Constellation Pharmaceuticals (CNST) United States $0.292B 0.00
Aduro Biotech (ADRO) United States $0.292B 0.00
MediciNova (MNOV) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Magenta Therapeutics (MGTA) United States $0.279B 0.00
Sorrento Therapeutics (SRNE) United States $0.276B 0.00
Solid Biosciences (SLDB) United States $0.275B 0.00
Axsome Therapeutics (AXSM) United States $0.273B 0.00
Merus (MRUS) Netherlands $0.272B 0.00
Intec Pharma (NTEC) Israel $0.265B 0.00
Geron (GERN) United States $0.265B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.258B 0.00
Liquidia Technologies (LQDA) United States $0.257B 0.00
AC Immune SA (ACIU) Switzerland $0.257B 0.00
Kadmon Holdings (KDMN) United States $0.256B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.249B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.231B 0.00
Celcuity (CELC) United States $0.229B 0.00
Synlogic (SYBX) United States $0.228B 0.00
Verastem (VSTM) United States $0.227B 0.00
Kamada (KMDA) Israel $0.227B 10.26
ResTORbio (TORC) United States $0.224B 0.00
MannKind (MNKD) United States $0.222B 0.00
Sutro Biopharma (STRO) United States $0.221B 0.00
Adverum Biotechnologies (ADVM) United States $0.220B 0.00
Strongbridge Biopharma (SBBP) United States $0.220B 0.00
Syros Pharmaceuticals (SYRS) United States $0.219B 0.00
TOCAGEN INC (TOCA) United States $0.216B 0.00
Athersys (ATHX) United States $0.213B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.205B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.202B 0.00
LogicBio Therapeutics (LOGC) United States $0.202B 0.00
Celyad SA (CYAD) Belgium $0.199B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
Compugen (CGEN) Israel $0.192B 0.00
Aptinyx (APTX) United States $0.191B 0.00
CorMedix Inc (CRMD) United States $0.187B 0.00
Cerecor (CERC) United States $0.184B 0.00
Protagonist Therapeutics (PTGX) United States $0.179B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.177B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.168B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.160B 0.00
Palatin Technologies (PTN) United States $0.159B 78.29
Menlo Therapeutics (MNLO) United States $0.155B 0.00
BioXcel Therapeutics (BTAI) United States $0.155B 0.00
Proteostasis Therapeutics (PTI) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.150B 0.00
Mersana Therapeutics (MRSN) United States $0.147B 0.00
OvaScience (MLND) United States $0.147B 0.00
BioTime (BTX) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.144B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.141B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.139B 0.00
Cohbar (CWBR) United States $0.129B 0.00
Unum Therapeutics (UMRX) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.128B 0.00
Trevena (TRVN) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Cue Biopharma (CUE) United States $0.126B 0.00
Pfenex (PFNX) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.123B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.120B 0.00
Mustang Bio (MBIO) United States $0.118B 0.00
Pluristem Therapeutics (PSTI) Israel $0.117B 0.00
XOMA (XOMA) United States $0.117B 0.00
Eton Pharmaceuticals (ETON) United States $0.115B 0.00
Equillium (EQ) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
VolitionRX (VNRX) Singapore $0.101B 0.00
VTv Therapeutics (VTVT) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Chiasma (CHMA) United States $0.092B 0.00
Neothetics (EVFM) United States $0.091B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
NantKwest (NK) United States $0.087B 0.00
Cel-Sci (CVM) United States $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.080B 88.67
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.076B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.074B 0.00
Aptose Biosciences (APTO) Canada $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Cidara Therapeutics (CDTX) United States $0.069B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.066B 12.63
SESEN BIO, INC (SESN) United States $0.061B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Ophthotech (OPHT) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.057B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
OVID THERAPEUTC (OVID) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
VIVUS (VVUS) United States $0.055B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
Alcobra (ARCT) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.61
VistaGen Therapeutics (VTGN) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.050B 0.00
Asterias Biotherapeutics (AST) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Selecta Biosciences (SELB) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Motif Bio Plc (MTFB) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Arsanis (ASNS) United States $0.040B 0.00
Caladrius Biosciences (CLBS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.032B 0.00
Galena Biopharma (SLS) United States $0.032B 0.00
Adial Pharmaceuticals (ADIL) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.030B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.030B 4.81
IMMURON LTD (IMRN) Australia $0.029B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
Oragenics (OGEN) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
Vical (VICL) United States $0.021B 0.00
Fibrocell Science Inc (FCSC) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
IBio (IBIO) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Soligenix (SNGX) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 6.93
Genetic Technologies (GENE) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
Hemispherx BioPharma (HEB) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00